Diversity of interferon γ and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis

Molecular Medicine

Volumn 14, Issue 5-6, 2008, Pages 247-256

  Flohé, Stefanie B ^a   Agrawal, Hemant ^a,b   Flohé, Sascha ^a   Rani, Meenakshi ^a   Bangen, Jörg M ^a   Schade, F Ulrich ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOMODULATION; LIGATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; TH1 CELL;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD86; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGES; MICE; MICE, INBRED BALB C; RECEPTORS, INTERFERON; SEPSIS;

EID: 44649084235     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00120.Flohe     Document Type: Article

References (45)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-10.
2. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88:1747-54.
3. Ayala A, Chaudry IH. (1996) Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock. 6 Suppl. 1:S27-38.
4. Ferguson NR, Galley HF, Webster NR. (1999) T helper cell subset ratios in patients with severe sepsis. Intensive Care Med. 25:106-9.
5. Heidecke CD, et al. (1999) Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am. J. Surg. 178:288-92.
6. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH. (1994) Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J. Surg. Res. 56:579-85.
7. Banchereau J, Steinman RM. (1998) Dendritic cells and the control of immunity. Nature. 392:245-52.
8. Edwards AD, et al. (2002) Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169:3652-60.
9. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-52.
10. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G. (1998) Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160:5936-44.
11. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166:4312-8.
12. Boonstra A, et al. (2006) Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177:7551-8.
13. Scumpia PO, et al. (2005) CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J. Immunol. 175:3282-6.
14. Hotchkiss RS, et al. (2002) Depletion of dendritic cells, but not macrophages, in patients with sepsis. J. Immunol. 168:2493-500.
15. Hiramatsu M, Hotchkiss RS, Karl IE, Buchman TG. (1997) Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock. 7:247-53.
16. Efron PA, et al. (2004) Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J. Immunol. 173:3035-43.
17. Tinsley KW, et al. (2003) Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J. Immunol. 171:909-14.
18. Guisset O, et al. (2007) Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med. 33:148-52.
19. Flohé SB, Agrawal H, Schmitz D, Gertz M, Flohé S, Schade FU. (2006) Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response. J. Leukoc. Biol. 79:473-81.
20. Benjamim CF, Lundy SK, Lukacs NW, Hogaboam CM, Kunkel SL. (2005) Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood. 105:3588-95.
21. Moreno SE, Alves-Filho JC, Alfaya TM, da Silva JS, Ferreira SH, Liew FY. (2006) IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J. Immunol. 177:3218-24.
22. Sparwasser T, et al. (1997) Bacterial DNA causes septic shock. Nature. 386:336-7.
23. Deng J, Muthu K, Gamelli R, Shankar R, Jones SB. (2004) Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis. Am. J. Physiol. Cell Physiol. 287:C730-6.
24. Ding Y, et al. (2004) Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock. 22:137-44.
25. Emmanuilidis K, et al. (2001) Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J. Immunol. 167:3919-27.
26. Yang S, Koo DJ, Zhou M, Chaudry IH, Wang P. (2000) Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am. J. Physiol. Gastrointest. Liver Physiol. 279:G1274-81.
27. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. (1999) T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today. 20:561-7.
28. Strobl H, Knapp W. (1999) TGF-beta1 regulation of dendritic cells. Microbes. Infect. 1:1283-90.
29. Maestroni GJ. (2002) Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J. Neuroimmunol. 129:106-14.
30. De Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. (1997) Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229-35.
31. Wen H, Hogaboam CM, Gauldie J, Kunkel SL. (2006) Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile. Am. J. Pathol. 168:1940-50.
32. Kovarik P, et al. (1999) Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 96:13956-61.
33. McLeish KR, et al. (1998) Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J. Leukoc. Biol. 64:537-45.
34. Rani M, Husain B, Lendemans S, Schade FU, Flohe S. (2006) Haemorrhagic shock in mice - intracellular signaling and immunomodulation of peritoneal macrophages' LPS response. Immunobiology. 211:711-9.
35. Welte T, Koch F, Schuler G, Lechner J, Doppler W, Heufler C. (1997) Granulocyte-macrophage colony-stimulating factor induces a unique set of STAT factors in murine dendritic cells. Eur. J. Immunol. 27:2737-40.
36. Flohé S, et al. (1999) Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass, and severe sepsis. Shock. 12:17-24.
37. Williams MA, et al. (1998) Granulocyte-macrophage colony-stimulating factor induces activation and restores respiratory burst activity in monocytes from septic patients. J. Infect. Dis. 177:107-15.
38. Nierhaus A, et al. (2003) Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 29:646-51.
39. Docke WD, et al. (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3:678-81.
40. Dries DJ, et al. (1994) Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch. Surg. 129:1031-41; discussion 1042.
41. Polk HC, Jr, et al. (1992) A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am. J. Surg. 163:191-6.
42. Mels AK, et al. (2001) Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma. Br. J. Surg. 88:539-44.
43. Rosenbloom AJ, Linden PK, Dorrance A, Penkosky N, Cohen-Melamed MH, Pinsky MR. (2005) Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest. 127:2139-50.
44. Toda H, et al. (1994) Effect of granulocyte-macrophage colony-stimulating factor on sepsis-induced organ injury in rats. Blood. 83:2893-8.
45. Kylanpaa ML, et al. (2005) Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas. 31:23-7.